There are many drugs out there that only work for a portion of patients, and personalized medicine approaches aim to direct patients to the drugs that will work for them. But, as the J. Craig Venter Institute's Nicholas Schork writes at Nature, standard clinical trials can't be used to test such personal interventions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.